Jefferies Financial Group’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
– Sell
-152,900
Closed -$12.4M – 1754
2023
Q4
$12.4M Buy
152,900
+34,500
+29% +$2.68M 0.08% 183
2023
Q3
$8.87M Buy
118,400
+2,400
+2% +$185K 0.08% 189
2023
Q2
$8.94M Buy
116,000
+11,300
+11% +$901K 0.08% 228
2023
Q1
$8.69M Buy
104,700
+30,000
+40% +$2.48M 0.07% 240
2022
Q4
$6.41M Buy
+74,700
New +$5.92M 0.04% 326

Other funds holding GILD

Jefferies Financial Group's GILD Position: Q2 2026 in Review

Jefferies Financial Group increased its Gilead Sciences (GILD) stake by 286% in Q2 2026, buying an estimated $33.8M and bringing the position to 345,805 shares worth $43.7M. The position accounts for 0.29% of the portfolio, ranked #74.

Jefferies Financial Group first reported a position in GILD in Q4 2022 and has held it in 15 quarters since. 2,290 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • Jefferies Financial Group held 345,805 shares of Gilead Sciences worth $43.7M as of Q2 2026.
  • Jefferies Financial Group bought 256,320 Gilead Sciences shares in Q2 2026, an estimated $33.8M.
  • Gilead Sciences made up 0.29% of Jefferies Financial Group's portfolio in Q2 2026, its #74 holding.
  • Jefferies Financial Group first reported a position in Gilead Sciences in Q4 2022 and has held it in 15 quarters since.
  • 2,290 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Jefferies Financial Group's 13F filing for Q2 2026, filed 17 Aug 2026.